We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
-41.26%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$7.37M
AUM Growth
-$7.35M
Cap. Flow
-$1.23M
Cap. Flow %
-16.66%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LUNG icon
Pulmonx
LUNG
+$1.23M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDVL
1
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$5.44M 73.8%
77,719
– –
LUNG icon
2
Pulmonx
LUNG
$87.6M
$1.93M 26.2%
60,204
-33,627
-36% -$1.23M

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
IWM
Immaculate Wealth Management Mesa, Arizona $12.7M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, ABG-WTT Global Life Science Capital Partners held 2 positions worth $7.37M, down 50% from $14.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners withdrew a net $1.23M in Q4 2021, reducing 1 holding. Its largest reduction was Pulmonx, cutting an estimated $1.23M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners's biggest Q4 2021 reduction was Pulmonx, cutting an estimated $1.23M.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $7.37M portfolio in Q4 2021.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q4 2021.
  • ABG-WTT Global Life Science Capital Partners's portfolio value fell 50% quarter-over-quarter to $7.37M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.